Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oncologic Therapy Support Via Means of a Dedicated Mobile App - a Prospective Feasibility Evaluation

NCT03168048 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT03168048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03168048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oncologic Therapy Support Via Means of a Dedicated Mobile App - a Prospective Feasibility Evaluation
Lead sponsor
Heidelberg University
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2017
Completion date
December 31, 2018
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, oncologic disorders, pelvic neoplasm, quality of life, radiotherapy; complications, satisfaction, thoracic neoplasm